Tang, T., Wang, G., Liu, S., Zhang, Z., Liu, C., Li, F., . . . Zhao, L. (2021). Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis. Nature Portfolio.
Style de citation Chicago (17e éd.)Tang, Tiantian, et al. Highly Expressed SLCO1B3 Inhibits the Occurrence and Development of Breast Cancer and Can Be Used as a Clinical Indicator of Prognosis. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Tang, Tiantian, et al. Highly Expressed SLCO1B3 Inhibits the Occurrence and Development of Breast Cancer and Can Be Used as a Clinical Indicator of Prognosis. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.